Cargando…

Application and risk prediction of thrombolytic therapy in cardio-cerebrovascular diseases: a review

Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide, consuming huge healthcare budget. For CVD patients, the prompt assessment and appropriate administration is the crux to save life and improve prognosis. Thrombolytic therapy, as a non-invasive approach to achieve recanal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Kexin, Jiang, Yao, Zeng, Hesong, Zhu, Hongling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476453/ https://www.ncbi.nlm.nih.gov/pubmed/37667349 http://dx.doi.org/10.1186/s12959-023-00532-0

Ejemplares similares

The Impact of Aging on Cardio and Cerebrovascular Diseases
por: Izzo, Carmine, et al.
Publicado: (2018)

Novel Drugs Development for Cardio-/Cerebrovascular Diseases
por: Sheu, Joen-Rong, et al.
Publicado: (2014)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

New Insights into Antithrombotic Therapy for Cardio- and Cerebrovascular Disease: From Molecular Mechanisms to Clinical Application
por: Cirillo, Plinio, et al.
Publicado: (2023)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Chinese herbal injection for cardio-cerebrovascular disease: Overview and challenges
por: Huajuan, Jiang, et al.
Publicado: (2023)

Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review
por: Zhang, Zixi, et al.
Publicado: (2023)

Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
por: Luo, Meng-Yi, et al.
Publicado: (2021)

Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease
por: Wang, Zi-Ying, et al.
Publicado: (2015)

miRNA Polymorphisms and Risk of Cardio-Cerebrovascular Diseases: A Systematic Review and Meta-Analysis
por: Bastami, Milad, et al.
Publicado: (2019)

Genetic Predispositions Between COVID-19 and Three Cardio-Cerebrovascular Diseases
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Association between gallstone and cardio-cerebrovascular disease: Systematic review and meta-analysis
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Dietary patterns and cardio-cerebrovascular disease in a Chinese population
por: Wang, Honglin, et al.
Publicado: (2015)

Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases
por: Bai, Xue, et al.
Publicado: (2020)

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
por: Su, Jian-Hui, et al.
Publicado: (2021)

Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.
por: Li, Dan, et al.
Publicado: (2022)

The Transfer Patterns of Vulnerable Populations with Acute Cardio-Cerebrovascular Diseases
por: Choi, E H, et al.
Publicado: (2023)

Increased risk of cardio-cerebrovascular disease after hematopoietic cell transplantation in patients with previous history
por: Peng, Bo, et al.
Publicado: (2021)

Seasonality and Cardio-Cerebrovascular Risk Factors for Benign Paroxysmal Positional Vertigo
por: Cao, Zhentang, et al.
Publicado: (2020)

Storax, A Promising Botanical Medicine for Treating Cardio-Cerebrovascular Diseases: A Review
por: Xu, Zhuo, et al.
Publicado: (2021)

Artificial Intelligence: A Shifting Paradigm in Cardio-Cerebrovascular Medicine
por: Abedi, Vida, et al.
Publicado: (2021)

Aspect of Thrombolytic Therapy: A Review
por: Ali, Md. Ramjan, et al.
Publicado: (2014)

Rheumatoid Arthritis and Cardio-Cerebrovascular Disease: A Mendelian Randomization Study
por: Qiu, Shizheng, et al.
Publicado: (2021)

Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases
por: Signori, Davide, et al.
Publicado: (2022)

The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases
por: Li, Jing, et al.
Publicado: (2023)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
por: Li, Mohan, et al.
Publicado: (2023)

Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis
por: Luo, Denggui, et al.
Publicado: (2021)

Associations between miR-146a rs2910164 polymorphisms and risk of ischemic cardio-cerebrovascular diseases
por: Zhao, Dongdong, et al.
Publicado: (2019)

Patient-Level Prediction of Cardio-Cerebrovascular Events in Hypertension Using Nationwide Claims Data
por: Park, Jaram, et al.
Publicado: (2019)

Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite
por: Gonzaga, Teresa, et al.
Publicado: (2016)

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
por: Lv, Jun-Xuan, et al.
Publicado: (2017)

The diagnosis and treatment of central retinal artery occlusion with severe cardio-cerebrovascular disease: a case report
por: Luo, Tian-Yi, et al.
Publicado: (2023)

Relationship between Parkinson’s disease and cardio-cerebrovascular diseases: a Mendelian randomized study
por: Zhou, Zhongzheng, et al.
Publicado: (2023)

The Role of Oxidative Stress in Common Risk Factors and Mechanisms of Cardio-Cerebrovascular Ischemia and Depression
por: Lin, Danfeng, et al.
Publicado: (2019)

Review of Stroke Thrombolytics
por: Bivard, Andrew, et al.
Publicado: (2013)

Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis
por: Yu, Jia-Ning, et al.
Publicado: (2020)

Homocysteine Is a Marker of Increased Cardio-Cerebrovascular Disease Risk in Psoriatic Patients, but It Does Not Reflect the Effect of Biological Therapy in the Longitudinal Observation
por: Baloghova, Janette, et al.
Publicado: (2022)

New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy
por: Karakurt, Ahmet
Publicado: (2018)

Anticoagulant and thrombolytic therapy in surgery /
por: Malinovskiĭ, Nikolaĭ N.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_j8m6fopa946qqukmmhlk90dkc5